Corticotropin-releasing factor and vasoactive intestinal polypeptide activate gene transcription through the cAMP signaling pathway in a catecholaminergic immortalized neuron

Neurochemistry International

Volumn 34, Issue 3, 1999, Pages 183-191

  Thiel, G ^a   Cibelli, G ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Corticotropin releasing factor; CREB; Immortalized neurons; Locus coeruleus; Protein kinase A inhibitor; Transcription; Vasoactive intestinal polypeptide

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CATECHOLAMINE NERVE CELL; CONTROLLED STUDY; GENE ACTIVATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; LOCUS CERULEUS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; CELL LINE, TRANSFORMED; CELL NUCLEUS; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA PRIMERS; ENZYME INHIBITORS; GENES, REPORTER; HUMANS; NEURONS; NOREPINEPHRINE; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0032909643     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(98)00086-2     Document Type: Article

References (68)

1. Armstrong R.C., Montminy M.R. Transsynaptic control of gene expression. Annu. Rev. Neurosci. 16:1993;7-29.
2. Abel T., Martin K.C., Bartsch D., Kandel E.R. Memory suppressor genes: inhibitory constraints on the storage of long-term memory. Science. 279:1998;338-341.
3. Bading H., Ginty D.D., Greenberg M.E. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science. 260:1993;181-186.
4. Bailey C.H., Bartsch D., Kandel E.R. Towards a molecular definition of long-term memory storage. Proc. Natl. Acad. Sci. USA. 93:1996;13445-13452.
5. Boutillier A.L., Monnier D., Lorang D., Lundblad J.R., Roberts J.L., Loeffler J.P. Corticotropin-releasing hormone stimulates proopiomelanocortin transcription by cFos-dependent and -independent pathways: characterization of an AP1 site in Exon 1. Molecular Endocrinology. 9:1995;745-755.
6. Boutillier A.L., Sassone-Corsi P., Loeffler J.P. The protooncogene c-fos is induced by corticotropin-releasing factor and stimulates proopiomelanocortin gene transcription in pituitary cells. Molecular Endocrinology. 5:1991;1301-1310.
7. Chang C-P., Pearse R.V. II, O'Connell S., Rosenfeld M.G. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron. 11:1993;1187-1195.
8. Chen F.M., Bilezikjian L.M., Perrin M.H., Rivier J., Vale W. Corticotropin releasing factor receptor-mediated stimulation of adenylate cylase activity in the rat brain. Brain Res. 381:1986;49-57.
9. Chen R., Lewis K.A., Perrin M.H., Vale W. Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl. Acad. Sci. USA. 90:1993;8967-8971.
10. Cibelli G., Jüngling S., Schoch S., Gerdes H-H., Thiel G. Identification of a functional cAMP response element in the secretogranin II gene. Eur. J. Biochem. 226:1996;171-179.
11. Cibelli G., Schoch S., Pajunk H., Brand I.A., Thiel G. A (G+C)-rich motif in the aldolase C promoter functions as a constitutive transcriptional enhancer element. Eur. J. Biochem. 237:1996;311-317.
12. Ciccarelli E., Vilardaga J-P., De Need P., Di Paolo E., Waelbroeck M., Bollen A., Robberecht P. Properties of the VIP-PACAP type II receptor stably expressed in CHO cells. Reg. Peptides. 54:1994;397-407.
13. Cicchetti P., Ridley A.J., Zheng Y., Cerione R.A., Baltimore D. 3BP-1, an SH3 domain binding protein, has GAP activity for Rac and inhibits growth factor-induced membrane ruffling in fibroblasts. EMBO. J. 14:1995;3127-3135.
14. Dorin R.I., Zlock D.W., Kilpatrick K. Transcriptional regulation of human corticotropin releasing factor gene expression by cyclic adenosine 3′,5′-mono-phosphate: differential effects at proximal and distal promoter elements. Mol. Cell. Endocrinol. 96:1993;99-111.
15. Duman R.S., Terwilliger R.Z., Nestler E.J. 'Locus coeruleus-like' cell line: a model system for studies of opiate and antidepressant drug action. Soc. Neurosci. Abstr. 18:1992;816.
16. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res. Rev. 15:1990;71-100.
17. Fantozzi D.A., Harootunian A.T., Wen W., Taylor S.S., Feramisco J.R., Tsien R.Y., Meinkoth J.L. Thermostable inhibitor of cAMP-dependent protein kinase enhances the rate of export of the kinase catalytic subunit from the nucleus. J. Biol. Chem. 269:1994;2676-2686.
18. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J. Jr, Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
19. Girault J.A., Shalaby I.A., Rosen N.L., Greengard P. Regulation by cAMP and vasoactive intestinal peptide of phosphorylation of specific proteins in striatal cells in culture. Proc. Natl. Acad. Sci. USA. 85:1988;7790-7794.
20. Gozes I., Brenneman D.E. VIP: Molecular biology and neurobiological function. Mol. Neurobiol. 3:1989;202-235.
21. Gray P.C., Scott J.D., Catterall W.A. Regulation of ion channels by cAMP-dependent protein kinase and A-kinase anchoring proteins. Curr. Opin. Neurobiol. 8:1998;330-334.
22. Grove J.R., Price D.J., Goodman H.M., Avruch J. Recombinant fragment of the protein kinase inhibitor blocks cyclic AMP-dependent gene transcription. Science. 238:1987;530-533.
23. Guardiola-Diaz H.M., Boswell C., Seasholtz A.F. The cAMP-responsive element in the corticotropin-releasing hormone gene mediates transcriptional regulation by depolarization. J. Biol. Chem. 20:1994;14784-14791.
24. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., Rawlings S.R., Robberecht P., Said S.I., Sreedharan S.P., Wank S.A., Waschek J.A. International union of pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev. 50:1998;265-270.
25. Hwang O., Park S., Kim K.S. Protein kinase A coordinately regulates both basal expression and cyclic AMP-mediated induction of three catecholamine-synthesizing enzyme genes. J. Neurochem. 68:1997;2241-2247.
26. 1 receptor expression by stress and agonist treatment in brain and cultured cells. Mol. Pharmacol. 50:1996;1103-1110.
27. Ishihara T., Shigemoto R., Mori K., Takahashi K., Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron. 8:1992;811-819.
28. Itoi K., Horiba N., Tozawa F., Sakai Y., Sakai K., Abe K., Demura H., Suda T. Major role of 3′,5′-cyclic adenosine monophosphate-dependent protein kinase A pathway in corticotropin-releasing factor gene expression in the rat hypothalamus in vivo. Endocrinology. 137:1996;2389-2396.
29. Jin W.D., Boutillier A-L., Glucksman M.J., Salton S.R.J., Loeffler J-P., Roberts J.L. Characterization of a corticotropin-releasing hormone-responsive element in the rat proopiomelanocortin gene promoter and molecular cloning of its binding protein. Mol. Endocrinol. 8:1994;1377-1388.
30. Jüngling S., Cibelli G., Czardybon M., Gerdes H-H., Thiel G. Differential regulation of chromogranin B and synapsin I gene promoter activity by cAMP and cAMP-dependent protein kinase. Eur. J. Biochem. 226:1994;925-935.
31. Kraus J., Höllt V. Identification of a cAMP-response element on the human proopiomelanocortin gene upstream promoter. DNA Cell. Biol. 14:1995;103-110.
32. Lalli E., Sassone-Corsi P. Signal transduction and gene regulation: the nuclear response to cAMP. J. Biol. Chem. 269:1994;17359-17362.
33. Lazaroff M., Patankar S., Yoon S.O., Chikaraishi D.M. The cyclic AMP response element directs tyrosine hydroxylase expression in catecholaminergic central and peripheral nervous system cell lines from transgenic mice. J. Biol. Chem. 270:1995;21579-21589.
34. Lazaroff M., Qi Y., Chikaraishi D.M. Differentiation of a catecholaminergic CNS cell line modifies tyrosine hydroxylase transcriptional regulation. J. Neurochem. 71:1998;51-59.
35. Lee T.J., Saito A., Berezin I. Vasoactive intestinal polypeptide-like substance: The potential transmitter for cerebral vasodilation. Science. 224:1984;898-901.
36. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B., Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. USA. 92:1995;836-840.
37. Luini A., Lewis D., Guild S., Corda D., Axelrod J. Hormone secretagogues increase cytosolic calcium by increasing cAMP in corticotropin-secreting cells. Proc. Natl. Acad. Sci. USA. 82:1995;8034-8038.
38. Lutz E.M., Sheward W.J., West K.M., Morrow J.A., Fink G., Harmar A.J. The VIP2 receptor: molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett. 334:1993;3-8.
39. Martin J-L., Dietl M.M., Hof P.R., Palacios J.M., Magistretti P.J. Autoradiographic mapping of [mono[125I]iodo-Tyr10,MetO17]-vasoactive intestinal peptide binding sites in the rat brain. Neuroscience. 23:1987;539-565.
40. Martin J-L., Gasser D., Magistretti P.J. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide potentiate c-fos expression induced by glutamate in cultured cortical neurons. J. Neurochem. 65:1995;1-9.
41. Matthews R.P., Guthrie C.R., Wailes L.M., Zhao X., Means A.R., McKnight G.S. Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression. Mol. Cell. Biol. 14:1994;6107-6116.
42. Melia K.R., Duman R.S. Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system. Proc. Natl. Acad. Sci. USA. 88:1991;8382-8386.
43. Montminy M.R. Control of transcription and cellular proliferation by cAMP. Karin M. Gene Expression: General and Cell-type-specific. 1993;76-92 Birkhuser, Boston.
44. Moss S.J., McDonald B.J., Rudhard Y., Schoepfer R. Phosphorylation of the predicted major intracellular domains of the rat and chick neuronal nicotinic acetylcholine receptor α 7 subunit by cAMP-dependent protein kinase. Neuropharmacol. 35:1996;1023-1028.
45. Muller A., Monnier D., Rene F., Larmet Y., Koch B., Loeffler J-P. Pituitary adenylate cyclase-activating polypeptide triggers dual transduction signaling in CATH.a cells and transcriptionally activates tyrosine hydroxylase and c-fos expression. J. Neurochem. 68:1997;1696-1704.
46. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43:1991;425-473.
47. Puri T.S., Gerhardstein B.L., Zhao X.L., Ladner M.B., Hosey M.M. Differential effects of subunit interactions on protein kinase A- and C-mediated phosphorylation of L-type calcium channels. Biochemistry. 36:1997;9605-9615.
48. Rawlings S.R., Hezareh M. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: actions on the anterior pituitary gland. Endocr. Rev. 17:1996;4-29.
49. Rohlff C., Ahmad S., Borellini F., Lei J., Glazer R.I. Modulation of transcription factor Sp1 by cAMP-dependent protein kinase. J. Biol. Chem. 22:1997;21137-21141.
50. Sánchez I., Hughes R.T., Mayer B.J., Yee K., Woodgett J.R., Avruch J., Kyriakis J.M., Zon L.I. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-jun. Nature. 372:1994;794-798.
51. Seasholtz A.F., Gamm D.M., Ballestero R.P., Scarletta M.A., Uhler M.D. Differential expression of mRNAs for protein kinase inhibitor isoforms in mouse brain. Proc. Natl. Acad. Sci. USA. 92:1995;1734-1738.
52. Scott J.D., Fischer E.H., Takio K., Demaille J.G., Krebs E.G. Amino acid sequence of the heat-stable inhibitor of the cAMP-dependent protein kinase from rabbit skeletal muscle. Proc. Natl. Acad. Sci. USA. 82:1985;5732-5736.
53. Sprengler D., Waeber C., Pantaloni C., Holsboer F., Bockaert J., Seeburg P.H., Journot L. Differential signal transduction by five splice variants of the PACAP receptor. Nature. 365:1993;170-175.
54. Stevens C.F. CREB and memory consolidation. Neuron. 13:1994;769-770.
55. 2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes Dev. 8:1994;2527-2539.
56. Suri C., Fung B.P., Tischler A.S., Chikaraishi D.H. Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T antigen transgenic mice. J. Neurosci. 13:1993;1280-1291.
57. Thiel G., Greengard P., Südhof T.C. Characterization of tissue-specific transcription by the human synapsin I gene promoter. Proc. Natl. Acad. Sci. USA. 88:1991;3431-3435.
58. Thiel G., Lietz M., Cramer M. Biological activity and modular structure of RE-1-silencing transcription factor (REST), a repressor of neuronal genes. J. Biol. Chem. 273:1998;26891-26899.
59. Thiel G., Petersohn D., Schoch S. pHIVTATA-CAT, a versatile vector to study transcriptional regulatory elements in mammalian cells. Gene. 168:1996;173-176.
60. Thiel G., Schoch S., Petersohn D. Regulation of synapsin I gene expression by the zinc finger transcription factor zif268/egr-1. J. Biol. Chem. 269:1994;15294-15301.
61. Tsukada T., Fink J.S., Mandel G., Goodman R.H. Identification of a region in the human vasoactive intestinal polypeptide gene responsible for regulation by cyclic AMP. J. Biol. Chem. 262:1987;8743-8747.
62. Valentino R.J., Page M.E., Curtis A.L. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res. 555:1991;25-34.
63. Vallejo M., Habener J.F. Mechanisms of transcriptional regulation by cAMP. Conaway R.C., Conaway J.W. Transcription: mechanisms and regulation. 1994;353-368 Raven Press, Ltd, New York.
64. Waeber G., Thompson N., Chautard T., Steinmann M., Nicod P., Pralong F.P., Calandra T., Gaillard R.C. Transcriptional activation of the macrophage migration-inhibitory factor gene by the corticotropin-releasing factor is mediated by the cyclic adenosine 3′,5′-monophosphate responsive element-binding protein CREB in pituitary cells. Mol. Endocrinol. 12:1998;698-705.
65. Westin G., Gerster T., Mller M.M., Schaffner G., Schaffner W. OVEC, a versatile system to study transcription in mammalian cells and cell-free extracts. Nucleic Acids Res. 17:1987;6787-6798.
66. Xing J., Kornhauser J.M., Xia Z., Thiele E.A., Greenberg M.E. Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol. Cell. Biol. 18:1998;1946-1955.
67. Zhong H., SuYang H., Erdjument-Bromage H., Tempst P., Ghosh S. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell. 89:1997;413-424.
68. Zhu Y., Ikeda S.R. VIP inhibits N-type Ca2+ channels of sympathetic neurons via a pertussis toxin-insensitive but cholera toxin-sensitive pathway. Neuron. 13:1994;657-669.